THE ASSOCIATION BETWEEN ANTHROPOMETRIC MEASURES OF OBESITY AND LEFT VENTRICULAR REVERSE REMODELLING WITH EMPAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES AND CORONARY ARTERY DISEASE: A SUB ANALYSIS OF THE EMPA-HEART CARDIOLINK-6 TRIAL.

Authors :: Puar, Pankaj
Hibino, Makoto
Ahmed, Shamon
Pasricha, Aryan
Pandey, Arjun
Bari, Amaan
Verma, Raj
Quan, Adrian
Teoh, Hwee
Connelly, Kim A.
Yan, Andrew T.
Mazer, C David
Verma, Subodh
Source :: Journal of the American College of Cardiology (JACC). 2023 Supplement, Vol. 81, p433-433. 1p.
Publication Year :: 2023

Subjects :: *TYPE 2 diabetes
*CORONARY artery disease
*VENTRICULAR remodeling
*EMPAGLIFLOZIN
*OBESITY

Full Text Access

Tools